开云app官网登录入口网页版-官方正版

#辅助疗法#

30篇内容 | 1564人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1650618, encodeId=75711650618f5, content=<a href='/topic/show?id=fde093e068f' target=_blank style='color:#2F92EE;'>#辅助疗法#</a>, objectTitle=JGH: 肠道微生物群衍生合生元配方 (SIM01) 可以作为COVID-19的新型辅助疗法, objectType=article, longId=728072, objectId=d699e280727f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d699e280727f, replyNumber=0, likeNumber=100, createdTime=2023-02-28, rootId=0, userName=sodoo, userId=bfce24047456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d699e280727f, moduleTitle=JGH: 肠道微生物群衍生合生元配方 (SIM01) 可以作为COVID-19的新型辅助疗法, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=d699e280727f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650617, encodeId=ae85165061eac, content=<a href='/topic/show?id=fde093e068f' target=_blank style='color:#2F92EE;'>#辅助疗法#</a>, objectTitle=J Dermatology Treat：认知行为疗法可作为精神性痤疮的辅助疗法 , objectType=article, longId=724497, objectId=375de244975f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=375de244975f, replyNumber=0, likeNumber=112, createdTime=2022-10-12, rootId=0, userName=sodoo, userId=bfce24047456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=375de244975f, moduleTitle=J Dermatology Treat：认知行为疗法可作为精神性痤疮的辅助疗法 , moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=375de244975f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650616, encodeId=c2a31650616ad, content=<a href='/topic/show?id=fde093e068f' target=_blank style='color:#2F92EE;'>#辅助疗法#</a>, objectTitle=重磅！FDA新批准：新辅助疗法纳武利尤单抗联合铂类用于治疗早期非小细胞肺癌, objectType=article, longId=301277, objectId=a25e3012e7e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a25e3012e7e9, replyNumber=0, likeNumber=92, createdTime=2023-01-19, rootId=0, userName=sodoo, userId=bfce24047456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a25e3012e7e9, moduleTitle=重磅！FDA新批准：新辅助疗法纳武利尤单抗联合铂类用于治疗早期非小细胞肺癌, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=a25e3012e7e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650619, encodeId=bced1650619d3, content=<a href='/topic/show?id=fde093e068f' target=_blank style='color:#2F92EE;'>#辅助疗法#</a>, objectTitle=Inflammopharmacology：褪黑激素可作为非手术治疗牙周炎的辅助疗法, objectType=article, longId=729261, objectId=a1f2e2926139, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a1f2e2926139, replyNumber=0, likeNumber=67, createdTime=2022-10-20, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a1f2e2926139, moduleTitle=Inflammopharmacology：褪黑激素可作为非手术治疗牙周炎的辅助疗法, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=a1f2e2926139)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650614, encodeId=27f116506145f, content=<a href='/topic/show?id=fde093e068f' target=_blank style='color:#2F92EE;'>#辅助疗法#</a>, objectTitle=JAMA Oncol：局部晚期结直肠癌的全新辅助疗法——放化疗+诱导/巩固化疗！, objectType=article, longId=221421, objectId=c3fc22142171, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c3fc22142171, replyNumber=0, likeNumber=102, createdTime=2022-08-04, rootId=0, userName=sodoo, userId=bfce24047456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c3fc22142171, moduleTitle=JAMA Oncol：局部晚期结直肠癌的全新辅助疗法——放化疗+诱导/巩固化疗！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=c3fc22142171)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650613, encodeId=b7b9165061323, content=<a href='/topic/show?id=fde093e068f' target=_blank style='color:#2F92EE;'>#辅助疗法#</a>, objectTitle=J Clin Oncol：肌层浸润性膀胱癌根治性切除术前予以吉西他滨+顺铂+派姆单抗新辅助疗法的效果, objectType=article, longId=216311, objectId=0e3021631188, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e3021631188, replyNumber=0, likeNumber=66, createdTime=2022-07-10, rootId=0, userName=sodoo, userId=bfce24047456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e3021631188, moduleTitle=J Clin Oncol：肌层浸润性膀胱癌根治性切除术前予以吉西他滨+顺铂+派姆单抗新辅助疗法的效果, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=0e3021631188)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650612, encodeId=612516506124d, content=<a href='/topic/show?id=fde093e068f' target=_blank style='color:#2F92EE;'>#辅助疗法#</a>, objectTitle=Br J Surg：负压伤口疗法作为儿童小面积热烧伤辅助疗法的有效性, objectType=article, longId=216099, objectId=2c6b216099b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c6b216099b1, replyNumber=0, likeNumber=91, createdTime=2022-05-03, rootId=0, userName=sodoo, userId=bfce24047456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c6b216099b1, moduleTitle=Br J Surg：负压伤口疗法作为儿童小面积热烧伤辅助疗法的有效性, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=2c6b216099b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650615, encodeId=0bd5165061587, content=<a href='/topic/show?id=fde093e068f' target=_blank style='color:#2F92EE;'>#辅助疗法#</a>, objectTitle=NICE推荐pembrolizumab单药作为3期黑色素瘤的辅助疗法, objectType=article, longId=292248, objectId=3be42922488a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3be42922488a, replyNumber=0, likeNumber=124, createdTime=2022-01-28, rootId=0, userName=sodoo, userId=bfce24047456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3be42922488a, moduleTitle=NICE推荐pembrolizumab单药作为3期黑色素瘤的辅助疗法, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=3be42922488a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650611, encodeId=ac4216506116a, content=<a href='/topic/show?id=fde093e068f' target=_blank style='color:#2F92EE;'>#辅助疗法#</a>, objectTitle=新英格兰：COVID-19疫苗诱导的血小板减少症的免疫球蛋白辅助疗法, objectType=article, longId=212672, objectId=62e72126e234, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=62e72126e234, replyNumber=0, likeNumber=93, createdTime=2022-04-17, rootId=0, userName=sodoo, userId=bfce24047456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=62e72126e234, moduleTitle=新英格兰：COVID-19疫苗诱导的血小板减少症的免疫球蛋白辅助疗法, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=62e72126e234)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650609, encodeId=39bf1650609f3, content=<a href='/topic/show?id=fde093e068f' target=_blank style='color:#2F92EE;'>#辅助疗法#</a>, objectTitle=Nature Medicine：一种突破性PTSD疗法：MDMA辅助疗法, objectType=article, longId=211212, objectId=757d21121236, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=757d21121236, replyNumber=0, likeNumber=92, createdTime=2022-04-08, rootId=0, userName=sodoo, userId=bfce24047456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=757d21121236, moduleTitle=Nature Medicine：一种突破性PTSD疗法：MDMA辅助疗法, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=757d21121236)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650601, encodeId=05a81650601e1, content=<a href='/topic/show?id=fde093e068f' target=_blank style='color:#2F92EE;'>#辅助疗法#</a>, objectTitle=J Neurointerv Surg：脑膜中动脉栓塞术可作为症状性慢性硬膜下血肿手术的辅助疗法, objectType=article, longId=204608, objectId=47ea20460880, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=47ea20460880, replyNumber=0, likeNumber=92, createdTime=2021-09-24, rootId=0, userName=sodoo, userId=bfce24047456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=47ea20460880, moduleTitle=J Neurointerv Surg：脑膜中动脉栓塞术可作为症状性慢性硬膜下血肿手术的辅助疗法, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=47ea20460880)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650602, encodeId=f6661650602a5, content=<a href='/topic/show?id=fde093e068f' target=_blank style='color:#2F92EE;'>#辅助疗法#</a>, objectTitle=阿斯利康的Tagrisso在美国被批准作为NSCLC的辅助疗法, objectType=article, longId=204703, objectId=fb3e204e03ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb3e204e03ee, replyNumber=0, likeNumber=79, createdTime=2021-10-22, rootId=0, userName=sodoo, userId=bfce24047456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb3e204e03ee, moduleTitle=阿斯利康的Tagrisso在美国被批准作为NSCLC的辅助疗法, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=fb3e204e03ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650607, encodeId=a778165060e3e, content=<a href='/topic/show?id=fde093e068f' target=_blank style='color:#2F92EE;'>#辅助疗法#</a>, objectTitle=Br J Cancer：ABCSG-34临床试验揭示新辅助疗法对于乳腺癌的效果, objectType=article, longId=209022, objectId=0ee1209022a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ee1209022a4, replyNumber=0, likeNumber=74, createdTime=2021-08-27, rootId=0, userName=sodoo, userId=bfce24047456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ee1209022a4, moduleTitle=Br J Cancer：ABCSG-34临床试验揭示新辅助疗法对于乳腺癌的效果, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=0ee1209022a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650610, encodeId=5e15165061025, content=<a href='/topic/show?id=fde093e068f' target=_blank style='color:#2F92EE;'>#辅助疗法#</a>, objectTitle=J Neurol Neurosurg Psychiatry：拉科萨姆可有效且安全的作为原发性全身强直-阵挛发作的辅助疗法, objectType=article, longId=211359, objectId=f2ec211359b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f2ec211359b1, replyNumber=0, likeNumber=84, createdTime=2021-10-17, rootId=0, userName=sodoo, userId=bfce24047456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f2ec211359b1, moduleTitle=J Neurol Neurosurg Psychiatry：拉科萨姆可有效且安全的作为原发性全身强直-阵挛发作的辅助疗法, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=f2ec211359b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650605, encodeId=8e45165060549, content=<a href='/topic/show?id=fde093e068f' target=_blank style='color:#2F92EE;'>#辅助疗法#</a>, objectTitle=Nat Med：黑色素瘤新辅助疗法病理反应和生存率的汇总分析研究, objectType=article, longId=207302, objectId=f64120e302ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f64120e302ed, replyNumber=0, likeNumber=81, createdTime=2021-12-01, rootId=0, userName=sodoo, userId=bfce24047456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f64120e302ed, moduleTitle=Nat Med：黑色素瘤新辅助疗法病理反应和生存率的汇总分析研究, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=f64120e302ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650608, encodeId=74c6165060864, content=<a href='/topic/show?id=fde093e068f' target=_blank style='color:#2F92EE;'>#辅助疗法#</a>, objectTitle=Br J Cancer：新辅助疗法治疗乳腺癌的回顾性观察研究, objectType=article, longId=209066, objectId=afb62090669a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=afb62090669a, replyNumber=0, likeNumber=86, createdTime=2022-02-20, rootId=0, userName=sodoo, userId=bfce24047456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=afb62090669a, moduleTitle=Br J Cancer：新辅助疗法治疗乳腺癌的回顾性观察研究, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=afb62090669a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650604, encodeId=dcda1650604e5, content=<a href='/topic/show?id=fde093e068f' target=_blank style='color:#2F92EE;'>#辅助疗法#</a>, objectTitle=TAVO联合OPDIVO作为黑色素瘤的新型辅助疗法：II期试验中患者首次给药, objectType=article, longId=205631, objectId=e7872056314a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e7872056314a, replyNumber=0, likeNumber=89, createdTime=2021-12-10, rootId=0, userName=sodoo, userId=bfce24047456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e7872056314a, moduleTitle=TAVO联合OPDIVO作为黑色素瘤的新型辅助疗法：II期试验中患者首次给药, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e7872056314a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650606, encodeId=50d7165060686, content=<a href='/topic/show?id=fde093e068f' target=_blank style='color:#2F92EE;'>#辅助疗法#</a>, objectTitle=Lancet oncol：阿特朱单抗用作高风险的肌肉浸润性尿路上皮癌的术后辅助疗法的疗效, objectType=article, longId=208560, objectId=971f208560b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=971f208560b8, replyNumber=0, likeNumber=74, createdTime=2022-02-08, rootId=0, userName=sodoo, userId=bfce24047456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=971f208560b8, moduleTitle=Lancet oncol：阿特朱单抗用作高风险的肌肉浸润性尿路上皮癌的术后辅助疗法的疗效, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=971f208560b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650603, encodeId=f2bc1650603a1, content=<a href='/topic/show?id=fde093e068f' target=_blank style='color:#2F92EE;'>#辅助疗法#</a>, objectTitle=FDA批准非小细胞肺癌的辅助疗法，疾病复发率降低80％, objectType=article, longId=205616, objectId=59bb205616aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=59bb205616aa, replyNumber=0, likeNumber=99, createdTime=2021-05-16, rootId=0, userName=sodoo, userId=bfce24047456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=59bb205616aa, moduleTitle=FDA批准非小细胞肺癌的辅助疗法，疾病复发率降低80％, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=59bb205616aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650599, encodeId=24b31650599af, content=<a href='/topic/show?id=fde093e068f' target=_blank style='color:#2F92EE;'>#辅助疗法#</a>, objectTitle=JAMA：治疗新冠病毒，近10款老药新用和3种辅助疗法的全新证据, objectType=article, longId=192573, objectId=b22a1925e3dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b22a1925e3dc, replyNumber=0, likeNumber=83, createdTime=2020-06-29, rootId=0, userName=sodoo, userId=bfce24047456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b22a1925e3dc, moduleTitle=JAMA：治疗新冠病毒，近10款老药新用和3种辅助疗法的全新证据, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=b22a1925e3dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

辅助疗法

2020-05-29

sodoo (审核中...)

前往app查看评论内容

#辅助疗法#

JGH: 肠道微生物群衍生合生元配方 (SIM01) 可以作为COVID-19的新型辅助疗法

2023-02-28

sodoo (审核中...)

前往app查看评论内容

#辅助疗法#

J Dermatology Treat：认知行为疗法可作为精神性痤疮的辅助疗法

2022-10-12

sodoo (审核中...)

前往app查看评论内容

#辅助疗法#

重磅！FDA新批准：新辅助疗法纳武利尤单抗联合铂类用于治疗早期非小细胞肺癌

2023-01-19

docwu2019 (审核中...)

前往app查看评论内容

#辅助疗法#

Inflammopharmacology：褪黑激素可作为非手术治疗牙周炎的辅助疗法

2022-10-20

sodoo (审核中...)

前往app查看评论内容

#辅助疗法#

JAMA Oncol：局部晚期结直肠癌的全新辅助疗法——放化疗+诱导/巩固化疗！

2022-08-04

sodoo (审核中...)

前往app查看评论内容

#辅助疗法#

J Clin Oncol：肌层浸润性膀胱癌根治性切除术前予以吉西他滨+顺铂+派姆单抗新辅助疗法的效果

2022-07-10

sodoo (审核中...)

前往app查看评论内容

#辅助疗法#

Br J Surg：负压伤口疗法作为儿童小面积热烧伤辅助疗法的有效性

2022-05-03

sodoo (审核中...)

前往app查看评论内容

#辅助疗法#

NICE推荐pembrolizumab单药作为3期黑色素瘤的辅助疗法

2022-01-28

sodoo (审核中...)

前往app查看评论内容

#辅助疗法#

新英格兰：COVID-19疫苗诱导的血小板减少症的免疫球蛋白辅助疗法

2022-04-17

sodoo (审核中...)

前往app查看评论内容

#辅助疗法#

Nature Medicine：一种突破性PTSD疗法：MDMA辅助疗法

2022-04-08

sodoo (审核中...)

前往app查看评论内容

#辅助疗法#

J Neurointerv Surg：脑膜中动脉栓塞术可作为症状性慢性硬膜下血肿手术的辅助疗法

2021-09-24

sodoo (审核中...)

前往app查看评论内容

#辅助疗法#

阿斯利康的Tagrisso在美国被批准作为NSCLC的辅助疗法

2021-10-22

sodoo (审核中...)

前往app查看评论内容

#辅助疗法#

Br J Cancer：ABCSG-34临床试验揭示新辅助疗法对于乳腺癌的效果

2021-08-27

sodoo (审核中...)

前往app查看评论内容

#辅助疗法#

J Neurol Neurosurg Psychiatry：拉科萨姆可有效且安全的作为原发性全身强直-阵挛发作的辅助疗法

2021-10-17

sodoo (审核中...)

前往app查看评论内容

#辅助疗法#

Nat Med：黑色素瘤新辅助疗法病理反应和生存率的汇总分析研究

2021-12-01

sodoo (审核中...)

前往app查看评论内容

#辅助疗法#

Br J Cancer：新辅助疗法治疗乳腺癌的回顾性观察研究

2022-02-20

sodoo (审核中...)

前往app查看评论内容

#辅助疗法#

TAVO联合OPDIVO作为黑色素瘤的新型辅助疗法：II期试验中患者首次给药

2021-12-10

sodoo (审核中...)

前往app查看评论内容

#辅助疗法#

Lancet oncol：阿特朱单抗用作高风险的肌肉浸润性尿路上皮癌的术后辅助疗法的疗效

2022-02-08

sodoo (审核中...)

前往app查看评论内容

#辅助疗法#

FDA批准非小细胞肺癌的辅助疗法，疾病复发率降低80％

2021-05-16

sodoo (审核中...)

前往app查看评论内容

#辅助疗法#

JAMA：治疗新冠病毒，近10款老药新用和3种辅助疗法的全新证据

2020-06-29

科室
- - 订阅+
  - 更多科室
工具
服务